// App-Quantinova.ai

9505 : Cardiovascular diseases after Hodgkin lymphoma treatment: 35-year disease risk and sequence of events.

Researchers

Presenter

  • Frederika A. van Nimwegen

Principal Investigators

  • Michael Schaapveld

  • Eefke J. Clevers-Petersen

  • Berthe M.P. Aleman

  • Flora E. van Leeuwen

Medical Centers

  • Department of Psychosocial Oncology and Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands

  • Erasmus Medical Center Cancer Institute, Department of Radiation Oncology, Rotterdam, NetherlandsDepartment of Hematology, University Medical Center Utrecht, Utrecht, NetherlandsLeiden University Medical Center, Department of Clinical Oncology, Leiden, Netherlands

  • Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands

  • Department of Pathology, the Netherlands Cancer Institute, Amsterdam, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Congestive heart failure

  • Cardiac valvular dysplasia X-linked

  • Coronary Artery Disease

  • Hodgkin's Lymphoma

  • Heart muscle disease

  • Lymphomas

  • Systemic inflammatory response syndrome

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved